Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes ...

Medtronic, a healthcare technology company based in Ireland, plans to separate its diabetes business into a standalone, publicly traded company by the end of 2026.  The company announced the move May ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

The company says it plans to separate the two entities within 18 months but will still need to get the approval of the ...

Medtronic plc revealed plans to spin off its underperforming diabetes unit as a separate public company during its fourth quarter 2025 earnings call on May 21. The company expects to complete the ...

Medtronic chairman and CEO Geoff Martha explains why the company is separating the diabetes business on 'The Claman Countdown ...

Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...